| __timestamp | Intra-Cellular Therapies, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 55962693 |
| Thursday, January 1, 2015 | 87718074 | 78655788 |
| Friday, January 1, 2016 | 93831530 | 95723069 |
| Sunday, January 1, 2017 | 79419009 | 116808575 |
| Monday, January 1, 2018 | 132166913 | 106397017 |
| Tuesday, January 1, 2019 | 89124838 | 108431600 |
| Wednesday, January 1, 2020 | 65782137 | 141426832 |
| Friday, January 1, 2021 | 88845513 | 225200000 |
| Saturday, January 1, 2022 | 134715000 | 297812160 |
| Sunday, January 1, 2023 | 180142000 | 283614139 |
Unlocking the unknown
In the dynamic world of biotechnology, innovation is the lifeblood that propels companies forward. Over the past decade, Intra-Cellular Therapies, Inc. and MorphoSys AG have been at the forefront of this innovation race, investing heavily in research and development (R&D) to bring groundbreaking therapies to market. From 2014 to 2023, MorphoSys AG consistently outpaced Intra-Cellular Therapies, Inc. in R&D spending, with an average annual investment that was approximately 55% higher. Notably, in 2022, MorphoSys AG's R&D expenses peaked at nearly 3 times their 2014 levels, underscoring their commitment to innovation. Meanwhile, Intra-Cellular Therapies, Inc. demonstrated a steady increase in R&D investment, culminating in a 2023 expenditure that was over 8 times their 2014 spending. This relentless pursuit of innovation by both companies highlights the critical role of R&D in driving the future of biotechnology.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
GSK plc or MorphoSys AG: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and MorphoSys AG
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Neurocrine Biosciences, Inc. vs MorphoSys AG
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG